Showing 98 of 98on this page. Filters & sort apply to loaded results; URL updates for sharing.98 of 98 on this page
Novocure Stock Soars After Wearable Device Shows Promise In Brain ...
Novocure wins reimbursement from Humana for Optune brain cancer device ...
Novocure earns Japanese approval for Optune Lua wearable device
NovoCure wins expanded indication for Optune device
Novocure submits tumor-treating fields device for FDA PMA
Novocure Gains FDA Approval for Enhanced Brain Cancer Device ...
Novocure wins FDA approval for electric field device in lung cancer ...
Novocure device succeeds in pancreatic cancer study; FDA sets ...
Novocure shares data from post-approval brain cancer device trial ...
A Wearable Device to Treat Brain Tumors | Novocure
Novocure mid-stage trial for electric fields device succeeds in ...
FDA Approves Novocure's Lung Cancer Treatment Device - Mugglehead ...
Novocure Logo
American federal agency approves new medical device for use in ...
Disrupting Cancer Cells on the Go: Novocure’s Optune Lua Device for ...
NovoCure’s wearable device receives FDA approval for metastatic cancer ...
Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor ...
Novocure’s device for metastatic NSCLC treatment gains CE Mark
Novocure Inc. | Virtual Booth | Connected Culture Expo site
Novocure calls on flex to design a brain cancer treatment
Electric Scalp Device Prolongs Survival in Deadly Brain Cancer - News ...
Novocure wins FDA nod for Optune Pax for pancreatic cancer
Novocure's electric fields device prolongs survival in lung cancer
Novocure wins FDA nod for lung cancer treatment wearable
Novocure: The Optune Device by brittany walker on Prezi
Novocure sees 6% spike from EU nod for electric lung cancer therapy ...
FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System ...
FDA approves Optune Pax TTR device + chemotherapy for the treatment of ...
Novocure stock surges nearly 30% after hours: FDA clears first new ...
FDA Approves Tumor Treating Fields Device (Optune Lua) for Metastatic ...
Novocure™ Receives Humanitarian Use Device Designation for Treatment of ...
Approval for pancreatic cancer treatment boosts Novocure - Globes
Brain cancer patients wear Novocure's (NVCR) Optune therapy device to ...
How Novocure is advancing brain cancer care - Brain Tumour Foundation ...
Novocure | Therapy for solid tumors called Tumor Treating Fields
Novocure’s lung cancer device extends survival in late-stage study ...
Case Study: Novocure Calls on Flex to Design a More Practical Brain ...
#patientforward | Novocure
Optune Lua® by Novocure Receives CE Mark Approval for Treating ...
Novocure Reviews and Ratings | Rannkly
Novocure Wins CE Mark for Lung Cancer Wearable – Medwire
Novocure MyLink OTU5000 Medical Equipment Manuals
Novocure's electric fields device approved for treating lung cancer in ...
Novocure Receives Approval for Optune Lua in Japan for Non-Small Cell ...
Novocure Announces CE Mark and First Patient Use of Second Generation ...
Novocure says electric field therapy extends life for pancreatic cancer ...
The complete system of TTF device (Optune ® ) includes a portable ...
novocure Optune Patient Information And Operation Manual | Manualzz
Novocure wins FDA nod for lung cancer treatment wearable - Start ...
Novocure and The Optune Gio – Path to Hope
Novocure announces the launch of MyLink, a new tool that allows ...
Novocure Therapy: Slows Lung Cancer Spread to Brain by 10 Months
Novocure wins FDA nod - Start Medical Product Development
In this photo illustration the NovoCure Limited logo seen displayed on ...
Novocure's device shown to slow cancer progression in the brain in ...
Novocure Announces Japanese Approval of Optune (the NovoTTF-100A System ...
Novocure logo in transparent PNG and vectorized SVG formats
Novocure Submits Premarket Approval Application to FDA for Tumor ...
Novocure - End Brain Cancer
Novocure Presents Phase 2 Pilot INNOVATE Trial Results Suggesting Tumor ...
Novocure opens new U.S. headquarters in Portsmouth - NH Business Review
NovoCure (NVCR) files 8-K with Q2 2025 results press release | NVCR SEC ...
FDA approves Novocure’s tumor field therapy for metastatic NSCLC
NCCN recommends Novocure’s Optune for newly diagnosed glioblastoma ...
Tumour Treating Fields (TTF) or Optune®
FDA approves Novocure’s treatment for mNSCLC - OncoDaily
Successful Phase III Clinical Trial Results Reported for NovoCure's ...
FDA Approves the NovoTTF-100A System for the Treatment of Patients With ...
Leveraging biophysics to fight the most aggressive forms of cancer
Novocure’s Tumor Treating Fields: Innovative brain cancer therapy with ...
Promising results of LUNAR trial for lung cancer, led by Winship ...
A treatment option for McCain: an electric cap that kills brain cancer ...
Novocure's Optune Lua approved in Japan for NSCLC treatment | Medical ...
FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With ...
Novacure's Wearable Lung Cancer Treatment Device, Optune Lua, Receives ...
FDA approves Novocure’s new flexible HFE arrays for glioblastoma
FDA approves Novocure’s Optune Pax for locally advanced pancreatic cancer
Novocure’s Optune Now Available at More Than 360 Cancer Treatment ...
FDA przyznała "zielone światło" dla terapii Optune (Novocure) w ...
FDA approves Novocure’s treatment for metastatic non-small cell lung ...
Novacure’s Wearable Lung Cancer Treatment Device, Optune Lua, Receives ...
Novocure’s stock rises 37% on FDA clearance of pancreatic cancer ...
Using electricity to treat cancer | Mirage News
2025 ｜ ノボキュア株式会社
U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally ...
FDA Grants Priority Review Status for Novocure’s PMA Supplement ...
Patients Who Used Optune® More Than 90 Percent of the Time Had the ...
Novocure's device-chemo combo boosts survival in pancreatic cancer ...
Flex - Netherlands - For the next generation Optune - Novocure's ...
